Significantly, our prior investigations have linked MRPL12-mediated regulation of mitochondrial biosynthesis, OXPHOS, and metabolism to the pathogenesis of diverse metabolic disorders, including ischemic and hypoxic conditions, as well as diabetes [18, 19]. The gene discussed is MRPL12; the disease is Other metabolic disease.